81 related articles for article (PubMed ID: 17891129)
41. Lidocaine for Cancer Pain in Adults: A Systematic Review and Meta-Analysis.
Lee JT; Sanderson CR; Xuan W; Agar M
J Palliat Med; 2019 Mar; 22(3):326-334. PubMed ID: 30614748
[TBL] [Abstract][Full Text] [Related]
42. The Effectiveness and Safety of Topical Capsaicin in Postherpetic Neuralgia: A Systematic Review and Meta-analysis.
Yong YL; Tan LT; Ming LC; Chan KG; Lee LH; Goh BH; Khan TM
Front Pharmacol; 2016; 7():538. PubMed ID: 28119613
[TBL] [Abstract][Full Text] [Related]
43. Transient benefits for topical hyaluronic acid in recurrent aphthous ulceration.
Porter S
Evid Based Dent; 2007; 8(2):52. PubMed ID: 17589493
[TBL] [Abstract][Full Text] [Related]
44. Open-Label Adhesion Performance Studies of a New Lidocaine Topical System 1.8% versus Lidocaine Patches 5% and Lidocaine Medicated Plaster 5% in Healthy Subjects.
Gudin J; Webster LR; Greuber E; Vought K; Patel K; Kuritzky L
J Pain Res; 2021; 14():513-526. PubMed ID: 33654425
[TBL] [Abstract][Full Text] [Related]
45. The effect of perineural injection therapy on neuropathic pain: a retrospective study.
Kim H; Kim HJ; Jung YH; Do W; Kim EJ
J Dent Anesth Pain Med; 2024 Feb; 24(1):47-56. PubMed ID: 38362256
[TBL] [Abstract][Full Text] [Related]
46. Open-Label Adhesion Performance Study of a Prescription Lidocaine Topical System 1.8% versus Three Lidocaine-Containing Over-the-Counter Patches in Healthy Subjects.
Fudin J; Vought K; Patel K; Lissin D; Maibach H
J Pain Res; 2022; 15():2051-2065. PubMed ID: 35923843
[TBL] [Abstract][Full Text] [Related]
47. A Randomized, Open-Label, Bioequivalence Study of Lidocaine Topical System 1.8% and Lidocaine Patch 5% in Healthy Subjects.
Gudin J; Argoff C; Fudin J; Greuber E; Vought K; Patel K; Nalamachu S
J Pain Res; 2020; 13():1485-1496. PubMed ID: 32606914
[TBL] [Abstract][Full Text] [Related]
48. Topical and intranasal analgesic therapy in a woman with refractory postherpetic neuralgia.
Hohmeier KC; Almon LM
Case Rep Med; 2015; 2015():392874. PubMed ID: 25949241
[TBL] [Abstract][Full Text] [Related]
49. Cutaneous targets for topical pain medications in patients with neuropathic pain: individual differential expression of biomarkers supports the need for personalized medicine.
Albrecht PJ; Liu Y; Houk G; Ruggiero B; Banov D; Dockum M; Day AJ; Rice FL; Bassani G
Pain Rep; 2024 Apr; 9(2):e1119. PubMed ID: 38375092
[TBL] [Abstract][Full Text] [Related]
50. The Efficacy of Systemic Lidocaine in the Management of Chronic Pain: A Literature Review.
Yousefshahi F; Predescu O; Francisco Asenjo J
Anesth Pain Med; 2017 Jun; 7(3):e44732. PubMed ID: 28856112
[TBL] [Abstract][Full Text] [Related]
51. Topical lignocaine for vaginismus: a case report.
Praharaj SK; Verma P; Arora M
Int J Impot Res; 2006; 18(6):568-9. PubMed ID: 16572189
[TBL] [Abstract][Full Text] [Related]
52. Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician.
Hans G; Robert D; Verhulst J; Vercauteren M
Clin Pharmacol; 2010; 2():65-70. PubMed ID: 22291487
[TBL] [Abstract][Full Text] [Related]
53. A Randomized, Crossover, Adhesion Performance and Pharmacokinetic Study of a Lidocaine Topical System Under Conditions of Water Exposure in Healthy Subjects.
Vought K; Greuber E; Patel K; Argoff C; Lissin D
J Pain Res; 2021; 14():2459-2467. PubMed ID: 34429646
[TBL] [Abstract][Full Text] [Related]
54. The life long burden of suffering from postherpetic neuralgia is reduced by adult vaccination and by topical anti-hyperalgesic treatment with lidocaine and capsaicin.
Breivik H
Scand J Pain; 2012 Oct; 3(4):218-219. PubMed ID: 29913865
[No Abstract] [Full Text] [Related]
55. Summaries of nursing care-related systematic reviews from the Cochrane Library: Topical capsaicin for chronic neuropathic pain in adults.
Norrie P
Int J Evid Based Healthc; 2010 Sep; 8(3):147-8. PubMed ID: 21199383
[No Abstract] [Full Text] [Related]
56. The RELIEF feasibility trial: topical lidocaine patches in older adults with rib fractures.
Battle C
Emerg Med J; 2024 Jun; ():. PubMed ID: 38825365
[No Abstract] [Full Text] [Related]
57. Our Topical Index.
Int Dent J (Phila); 1889 Jan; 10(1):55-56. PubMed ID: 37910974
[No Abstract] [Full Text] [Related]
58. Insufficient evidence to recommend topical lidocaine as first-line treatment for postherpetic neuralgia.
Zakrzewska JM
Evid Based Dent; 2007; 8(3):85-6. PubMed ID: 17891129
[TBL] [Abstract][Full Text] [Related]
59. Topical lidocaine for the treatment of postherpetic neuralgia.
Khaliq W; Alam S; Puri N
Cochrane Database Syst Rev; 2007 Apr; (2):CD004846. PubMed ID: 17443559
[TBL] [Abstract][Full Text] [Related]
60. Robust randomised control trials needed for drug treatments for trigeminal neuralgia.
Zakrzewska JM
Evid Based Dent; 2006; 7(4):107. PubMed ID: 17187047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
